Sp412
MANAGEMENT OF GASTROINTESTINAL COMPLICATIONS OF IMMUNOTHERAPY
Date
May 19, 2024
Explore related products in the following collection:
Presenter
Tracks
Related Products
THE IMPACT OF PROTON-PUMP INHIBITOR USE ON THE INCIDENCE OF GASTROINTESTINAL TOXICITY TO CHECKPOINT INHIBITION
Background: Immune checkpoint inhibitors (ICIs) are used to treat several malignancies but predispose to systemic autoimmune inflammation referred to as immune-related adverse events (irAE). Upper and lower gastrointestinal (GI) tract inflammation are commonly encountered toxicities…
